Retatrutide 30mg

Retatrutide 30mg is a synthetic research peptide classified as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. It is currently under clinical investigation for its potential effects on metabolic regulation, including glucose control and energy balance. This compound is intended strictly for laboratory and research use only and is not approved for human consumption or medical use.